300 related articles for article (PubMed ID: 26898664)
1. Frequency, clinical manifestations, and outcomes of Staphylococcus lugdunensis Bacteremia in children.
Sato M; Kubota N; Horiuchi A; Kasai M; Minami K; Matsui H
J Infect Chemother; 2016 May; 22(5):298-302. PubMed ID: 26898664
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan.
Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852
[TBL] [Abstract][Full Text] [Related]
3. The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review.
Non LR; Santos CA
J Infect; 2017 Feb; 74(2):179-186. PubMed ID: 27777118
[TBL] [Abstract][Full Text] [Related]
4. Emergence of oxacillin-resistant Staphylococcus lugdunensis carrying staphylococcal cassette chromosome mec type V in central Taiwan.
Yen TY; Sung YJ; Lin HC; Peng CT; Tien N; Hwang KP; Lu JJ
J Microbiol Immunol Infect; 2016 Dec; 49(6):885-891. PubMed ID: 25648670
[TBL] [Abstract][Full Text] [Related]
5. Genotypes and phenotypes of Staphylococcus lugdunensis isolates recovered from bacteremia.
Tseng SP; Lin YT; Tsai JC; Hung WC; Chen HJ; Chen PF; Hsueh PR; Teng LJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):397-405. PubMed ID: 24388577
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.
McHardy IH; Veltman J; Hindler J; Bruxvoort K; Carvalho MM; Humphries RM
J Clin Microbiol; 2017 Feb; 55(2):585-595. PubMed ID: 27927926
[TBL] [Abstract][Full Text] [Related]
7. Persistence of a major endemic clone of oxacillin-resistant Staphylococcus lugdunensis sequence type 6 at a tertiary medical centre in northern Taiwan.
Cheng CW; Liu TP; Yeh CF; Lee MH; Chang SC; Lu JJ
Int J Infect Dis; 2015 Jul; 36():72-7. PubMed ID: 26051975
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features, Outcomes, and Molecular Characteristics of Community- and Health Care-Associated Staphylococcus lugdunensis Infections.
Yeh CF; Chang SC; Cheng CW; Lin JF; Liu TP; Lu JJ
J Clin Microbiol; 2016 Aug; 54(8):2051-7. PubMed ID: 27225402
[TBL] [Abstract][Full Text] [Related]
9. Coagulase-negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility.
Huang SY; Tang RB; Chen SJ; Chung RL
J Microbiol Immunol Infect; 2003 Mar; 36(1):51-5. PubMed ID: 12741734
[TBL] [Abstract][Full Text] [Related]
10. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
Liang M; Mansell C; Wade C; Fisher R; Devlin G
N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
[TBL] [Abstract][Full Text] [Related]
11. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus lugdunensis carrying SCCmec type V misidentified as MRSA.
Pereira EM; Schuenck RP; Nouér SA; Santos KR
Braz J Infect Dis; 2011; 15(3):293-5. PubMed ID: 21670934
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options.
Taha L; Stegger M; Söderquist B
Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1449-1455. PubMed ID: 31144243
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus lugdunensis: low prevalence and clinical significance in a pediatric microbiology laboratory.
German GJ; Wang B; Bernard K; Stewart N; Chan F; Pacheco AL; Wiebe D; Burdz T; Slinger R
Pediatr Infect Dis J; 2013 Jan; 32(1):87-9. PubMed ID: 23241991
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.
Hitzenbichler F; Simon M; Salzberger B; Hanses F
Infection; 2017 Apr; 45(2):179-186. PubMed ID: 27660064
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and antimicrobial susceptibility of Staphylococcus lugdunensis in a Greek tertiary-care hospital.
Kachrimanidou M; Malliou P; Meletis G; Netsika F; Mavrovouniotis I; Protonotariou E; Skoura L
New Microbiol; 2020 Jul; 43(3):133-135. PubMed ID: 32596739
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.
Farrell DJ; Mendes RE; Bensaci M
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):85-88. PubMed ID: 30314652
[TBL] [Abstract][Full Text] [Related]
18. Multicenter retrospective cohort study of the clinical significance of Staphylococcus lugdunensis isolated from a single blood culture set.
Hauser N; Kim JJ; Luethy PM; Schmalzle SA; Bork JT
Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115261. PubMed ID: 33290922
[TBL] [Abstract][Full Text] [Related]
19. First record of isolation and characterization of methicillin resistant Staphylococcus lugdunensis from clinical samples in Iraq.
Al-Charrakh AH; Obayes MH
Biomed Res Int; 2014; 2014():736259. PubMed ID: 25126573
[TBL] [Abstract][Full Text] [Related]
20. Accurate detection of oxacillin-resistant Staphylococcus lugdunensis by use of agar dilution.
Kao CY; Wu HH; Chang SC; Lin LC; Liu TP; Lu JJ
J Microbiol Immunol Infect; 2022 Apr; 55(2):234-240. PubMed ID: 33836942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
